Edition:
India

Biospecifics Technologies Corp (BSTC.OQ)

BSTC.OQ on NASDAQ Stock Exchange Global Market

42.81USD
2:29am IST
Change (% chg)

$-0.08 (-0.19%)
Prev Close
$42.89
Open
$42.87
Day's High
$43.09
Day's Low
$42.53
Volume
5,630
Avg. Vol
6,898
52-wk High
$58.36
52-wk Low
$41.95

Chart for

About

BioSpecifics Technologies Corp. is a biopharmaceutical company involved in the development of an injectable collagenase clostridium histolyticum for multiple indications. The Company has a development and license agreement with Endo Global Ventures, a Bermuda unlimited liability company (Endo Global Ventures), an affiliate of... (more)

Overall

Beta: 1.67
Market Cap(Mil.): $350.55
Shares Outstanding(Mil.): 7.16
Dividend: --
Yield (%): --

Financials

BRIEF-Biospecifics Technologies reports Q3 eps of $0.37

* Biospecifics Technologies Corp reports Q3 2017 financial results

10 Nov 2017

BRIEF-BioSpecifics Technologies reports Q2 earnings per share $0.36

* BioSpecifics Technologies Corp reports second quarter 2017 financial results

10 Aug 2017

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $138.34 +0.41
Novartis AG (NOVN.S) CHF83.55 +0.45
Pfizer Inc. (PFE.N) $35.54 +0.19
Roche Holding Ltd. (ROG.S) CHF244.00 +0.40
Roche Holding Ltd. (RO.S) CHF245.60 -0.40
Merck & Co., Inc. (MRK.N) $54.27 +0.17
Bayer AG (BAYGn.DE) €109.65 +1.00
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €76.44 +0.69
GlaxoSmithKline plc (GSK.L) 1,303.00 -10.50

Earnings vs. Estimates